使

Antti I Nykänen1,2,3, Mingyao Liu1,2, Shaf Keshavjee1,2

  • 1Latner Thoracic Surgery Research Laboratories, Toronto General Research Hospital Institute, University Health Network, Toronto, ON M5G 1L7, Canada.

概括

介酶体 stromal 细胞 (MSC) 在保护捐赠者的肺部免受损伤和肺部移植后的排斥方面表现有前途. 研究探索MSCs用于预防和治疗慢性肺异位移植功能障碍 (CLAD).